Ryan Murr > Gibson, Dunn & Crutcher LLP > San Francisco, United States > Lawyer Profile

Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco, CA 94105-0921
CALIFORNIA
United States

Work Department

Life Sciences, Corporate, Capital Markets

Position

Ryan currently serves as co-chair of Gibson Dunn’s Life Sciences Practice Group, as well as co-partner-in-charge of the firm’s San Francisco office. Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, licensing transactions and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.

Lawyer Rankings

United States > Healthcare > Life sciences

(Leading partners)

Ryan MurrGibson, Dunn & Crutcher LLP

Gibson, Dunn & Crutcher LLP’s life sciences practice represents biotech, pharma, and medical device companies in IP and corporate and commercial transactions. The firm has a strong transactional team advising both issuers and financial institutions in deals across M&A, venture financing, stock and asset acquisitions, and private and public securities offerings. Its patent litigation expertise includes cases under the Hatch-Waxman Act, as well as the enforcement of second- and third-generation, combination drug, and formulation patents. The practice is co-chaired by San Francisco’s Ryan Murr, who is vastly experienced in capital markets transactions, M&A, royalty financing, and corporate governance. Also co-chair, New York-based Jane Love handles high-value patent litigation, patent prosecution, and diligence advice connected to transactions.